{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:36:51Z","timestamp":1788305811030,"version":"build-2803163510"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":3827,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Clinical Nutrition"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.3945\/ajcn.112.040642","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T20:19:35Z","timestamp":1343938775000},"page":"672-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"96","author":[{"given":"Jessica A","family":"Alvarez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn E","family":"Coakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susu M","family":"Zughaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khadijeh","family":"Shahid Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haimanot","family":"Wasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orlando M","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin","family":"Tangpricha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3 suppl 3","key":"10.3945\/ajcn.112.040642_bib1","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1053\/j.ajkd.2008.07.054","article-title":"CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES)","volume":"53","author":"Castro","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.112.040642_bib2","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ki.2011.368","article-title":"The contribution of chronic kidney disease to the global burden of major noncommunicable diseases","volume":"80","author":"Couser","year":"2011","journal-title":"Kidney Int"},{"key":"10.3945\/ajcn.112.040642_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.3945\/ajcn.112.040642_bib4","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5 suppl 5","key":"10.3945\/ajcn.112.040642_bib5","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1053\/ajkd.2001.28113","article-title":"Secondary hyperparathyroidism in chronic renal failure: pathogenic and clinical aspects","volume":"38","author":"Llach","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.112.040642_bib6","doi-asserted-by":"crossref","unstructured":"National Kidney Foundation. K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(4 suppl 3):S1\u2013201.","DOI":"10.1016\/S0272-6386(03)00905-3"},{"key":"10.3945\/ajcn.112.040642_bib7","doi-asserted-by":"crossref","unstructured":"Alvarez JA, Wasse H, Tangpricha V. Vitamin D supplementation in chronic kidney disease: a systematic review. Dermato-Endocrinology 2012;4 (in press). Available from: http:\/\/www.landesbioscience.com\/journals\/dermatoendocrinology\/toc\/volume\/4\/issue\/2\/.","DOI":"10.4161\/derm.20014"},{"key":"10.3945\/ajcn.112.040642_bib8","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2010-2230","article-title":"Vitamin D3 is more potent than vitamin D2 in humans","volume":"96","author":"Heaney","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.112.040642_bib9","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1210\/jc.2008-2012","article-title":"Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light","volume":"94","author":"Khazai","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.112.040642_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.3945\/ajcn.112.040642_bib11","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1440-1797.2011.01450.x","article-title":"Shining D\u2019 light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D","volume":"16","author":"Petchey","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.3945\/ajcn.112.040642_bib12","doi-asserted-by":"crossref","unstructured":"Lishmanov A, Dorairajan S, Pak Y, Chaudhary K, Chockalingam A. Treatment of 25-OH vitamin D deficiency in older men with chronic kidney disease stages 3 and 4 is associated with reduction in cardiovascular events. Am J Ther (Epub ahead of print 17 August 2011).","DOI":"10.1053\/j.ajkd.2011.02.173"},{"key":"10.3945\/ajcn.112.040642_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11906-011-0190-2","article-title":"Vitamin d therapy and cardiovascular health","volume":"13","author":"Judd","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"10.3945\/ajcn.112.040642_bib14","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3945\/ajcn.112.040642_bib15","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2011-0398","article-title":"Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis","volume":"96","author":"Elamin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.112.040642_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.7326\/0003-4819-152-5-201003020-00009","article-title":"Systematic review: vitamin D and cardiometabolic outcomes","volume":"152","author":"Pittas","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.3945\/ajcn.112.040642_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2215\/CJN.07131009","article-title":"A randomized trial of cholecalciferol versus doxercalciferol for lowering parathyroid hormone in chronic kidney disease","volume":"5","author":"Moe","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib18","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.2215\/CJN.02640310","article-title":"Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the \u201ctrade-off\u201d hypothesis","volume":"5","author":"Guti\u00e9rrez","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib19","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.3945\/ajcn.112.040642_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.3945\/ajcn.112.040642_bib21","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.112.040642_bib22","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1525-139X.2010.00743.x","article-title":"Dietary assessment of individuals with chronic kidney disease","volume":"23","author":"Bross","year":"2010","journal-title":"Semin Dial"},{"key":"10.3945\/ajcn.112.040642_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2215\/CJN.05781207","article-title":"Hypovitaminosis D in chronic kidney disease","volume":"3","author":"Mehrotra","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"10.3945\/ajcn.112.040642_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4158\/EP.14.1.10","article-title":"Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study","volume":"14","author":"Chandra","year":"2008","journal-title":"Endocr Pract"},{"key":"10.3945\/ajcn.112.040642_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.ajkd.2007.04.010","article-title":"Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD","volume":"50","author":"Al-Aly","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.112.040642_bib27","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1053\/j.ajkd.2011.06.027","article-title":"Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial","volume":"59","author":"Kovesdy","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.112.040642_bib28","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5414\/CNP73276","article-title":"Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K\/DOQI treatment guidelines adequate?","volume":"73","author":"Qunibi","year":"2010","journal-title":"Clin Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib29","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2215\/CJN.04760511","article-title":"Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial","volume":"7","author":"Shroff","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib30","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2215\/CJN.03050608","article-title":"Association of serum intact parathyroid hormone with lower estimated glomerular filtration rate","volume":"4","author":"Muntner","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib31","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2215\/CJN.10030911","article-title":"Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23","volume":"7","author":"Burnett-Bowie","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/EJE-10-0591","article-title":"Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term","volume":"163","author":"Uzum","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.3945\/ajcn.112.040642_bib33","doi-asserted-by":"crossref","first-page":"F1577","DOI":"10.1152\/ajprenal.00463.2006","article-title":"Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro","volume":"293","author":"Perwad","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.3945\/ajcn.112.040642_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"10.3945\/ajcn.112.040642_bib35","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","article-title":"Regulation of fibroblast growth factor-23 in chronic kidney disease","volume":"22","author":"Westerberg","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.3945\/ajcn.112.040642_bib36","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.beem.2011.04.001","article-title":"Epidemiology of cardiovascular risks and events","volume":"25","author":"Leu","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.3945\/ajcn.112.040642_bib37","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","volume":"111","author":"Pickering","year":"2005","journal-title":"Circulation"},{"key":"10.3945\/ajcn.112.040642_bib38","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2215\/CJN.06510909","article-title":"Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters","volume":"5","author":"Matias","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib39","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2215\/CJN.00900208","article-title":"Exploration of association of 1,25-OH2D3 with augmentation index, a composite measure of arterial stiffness","volume":"3","author":"Andrade","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.3945\/ajcn.112.040642_bib40","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/HYPERTENSIONAHA.107.086942","article-title":"Pulse wave velocity is inversely related to vertebral bone density in hemodialysis patients","volume":"49","author":"Raggi","year":"2007","journal-title":"Hypertension"},{"key":"10.3945\/ajcn.112.040642_bib41","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jacc.2011.02.051","article-title":"Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans","volume":"58","author":"Al Mheid","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.3945\/ajcn.112.040642_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"key":"10.3945\/ajcn.112.040642_bib43","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"10.3945\/ajcn.112.040642_bib44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/j.ajkd.2007.04.015","article-title":"25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)","volume":"50","author":"de Boer","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.3945\/ajcn.112.040642_bib45","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1053\/j.jrn.2010.07.002","article-title":"Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions","volume":"21","author":"Isakova","year":"2011","journal-title":"J Ren Nutr"},{"key":"10.3945\/ajcn.112.040642_bib46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/HYPERTENSIONAHA.108.113159","article-title":"Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial","volume":"52","author":"Alborzi","year":"2008","journal-title":"Hypertension"},{"key":"10.3945\/ajcn.112.040642_bib47","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(10)61032-X","article-title":"Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial","volume":"376","author":"de Zeeuw","year":"2010","journal-title":"Lancet"},{"key":"10.3945\/ajcn.112.040642_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/MNH.0b013e32834de4ee","article-title":"Vitamin D: roles in renal and cardiovascular protection","volume":"21","author":"Li","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.3945\/ajcn.112.040642_bib49","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ki.2010.543","article-title":"Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease","volume":"79","author":"Dusso","year":"2011","journal-title":"Kidney Int"}],"container-title":["The American Journal of Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523029684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002916523029684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ajcn\/article-pdf\/96\/3\/672\/23817385\/672.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T04:12:51Z","timestamp":1685160771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002916523029684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0002916523029684"],"URL":"https:\/\/doi.org\/10.3945\/ajcn.112.040642","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954671.793466054","asserted-by":"object"}]},"ISSN":["0002-9165"],"issn-type":[{"value":"0002-9165","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3945\/ajcn.112.040642","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Nutrition. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}